Schizophrenia & Other Psychotic Disorders
From the Journals
Ketamine and psychosis risk: New data
“Our findings could encourage clinicians and researchers to examine a broadened indication for ketamine treatment,” said Dr. Jolien K.E. Veraart...
From the Journals
Strong support for causal role of cannabis in schizophrenia
"Our study clearly indicates that cannabis should not be considered harmless," wrote Dr. Carsten Hjorthøj.
Feature
Psychiatric genomics has a diversity problem
For a long time researchers thought including “multiple ancestries in first rounds of genetic analyses” was too complicated, said Dr. Laramie...
Feature
State-of-the-art psych unit designed with recovery in mind
The new unit is designed both architecturally and clinically to deliver 'trauma-informed' care.
Shrink Rap News
Britney Spears and her 13-year conservatorship: An abuse of involuntary care?
Where are the conservators for those who live in the streets? Dr. Dinah Miller asks.
Commentary
More on long-acting injectable antipsychotics
I want to thank Dr. Nasrallah for his editorial calling for more frequent and earlier use of long-acting injectable antipsychotics (LAIs) in...
Pearls
Treating psychosis in pregnant women: A measured approach
The peak age of onset of schizophrenia coincides with the peak childbearing age of 25 to 35 years.
Conference Coverage
Long-acting injectable antipsychotics deserve first-line consideration
Circumventing large risks of nonadherence, long-acting injectables should be an option considered routinely, said Dr. Diana Perkins.
Conference Coverage
Emerging drugs for schizophrenia targeting negative symptoms
Several antipsychotics that show efficacy against negative symptoms are in advanced stages of development, said Dr. Henry A. Nasrallah.
Feature
How a community-based program for SMI pivoted during the pandemic
Fountain House now faces new challenges operating as a possible hybrid model, Dr. Ashwin Vasan said.
From the Journals
Cortical thinning in adolescence ‘definitively’ tied to subsequent psychosis
"This is the first study to definitively show that there are subtle, widespread structural brain differences in high-risk youth before they...